A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Conditions
Multiple Sclerosis · Myasthenia Gravis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
University of California, Irvine, Irvine, California, United States
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Colorado Blood Cancer Institute, Denver, Colorado, United States
Yale-New Haven Hospital, New Haven, Connecticut, United States
University of Kansas Medical Center, Kansas City, Kansas, United States
Local Institution - 0039, New Orleans, Louisiana, United States
Local Institution - 0005, Boston, Massachusetts, United States
Washington University School of Medicine, St Louis, Missouri, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Neurological Institute of New York, New York, New York, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Cleveland Clinic Mellen Center, Cleveland, Ohio, United States
Oregon Health and Science University, Portland, Oregon, United States
Swedish Medical Center, Seattle, Washington, United States
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Antwerp University Hospital, Edegem, Antwerpen, Belgium
UZ Gent, Ghent, Oost-Vlaanderen, Belgium
Hopital Claude Huriez - CHU de Lille, Lille, Nord, France
Pitie Salpetriere University Hospital, Paris, Ville de Paris, France
Universitaetsklinikum Essen, Essen, North Rhine-Westphalia, Germany
Universitaetsklinikum Magdeburg, Magdeburg, Saxony-Anhalt, Germany
Local Institution - 0033, Düsseldorf, Germany
Universitaetsklinikum Erlangen, Erlangen, Germany
Klinikum der Universität München Großhadern, München, Germany
Hospital Universitari Vall d'Hebron, Barcelona, Barcelona [Barcelona], Spain
Local Institution - 0016, Barcelona, Barcelona [Barcelona], Spain
Hospital Clínic de Barcelona, Barcelona, Catalunya [Cataluña], Spain
Hospital Universitario Ramón y Cajal, Madrid, Madrid, Comunidad de, Spain
Hospital Universitari i Politecnic La Fe, Valencia, Spain
Manchester Royal Infirmary, Manchester, Lancashire, United Kingdom
University College London Hospital, London, London, City of, United Kingdom
Salford Royal Hospital, Salford, Manchester, United Kingdom
Barts Health NHS Trust, London, United Kingdom
Study leads
Bristol-Myers Squibb
Study Director
Bristol-Myers Squibb